GALERA THERAPEUTICS INC (GRTX)

US36338D1081 - Common Stock

0.145  -0.07 (-32.59%)

After market: 0.1379 -0.01 (-4.9%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

GALERA THERAPEUTICS INC

NASDAQ:GRTX (6/3/2024, 7:18:13 PM)

After market: 0.1379 -0.01 (-4.9%)

0.145

-0.07 (-32.59%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS SubIndustry
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%
Sales Q2Q%
CRS
6 Month12.4%
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap7.89M
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

GRTX Daily chart

Company Profile

Galera Therapeutics, Inc. is a clinical stage biotechnology company, which engages in developing and commercializing a pipeline of novel, proprietary therapeutics for cancer. The company is headquartered in Malvern, Pennsylvania and currently employs 31 full-time employees. The company went IPO on 2019-11-07. The firm is focused on developing and commercializing a pipeline of therapeutic candidates to transform radiotherapy in cancer. Its lead product candidate, avasopasem manganese (GC4419), is a small molecule dismutase mimetic in development for the reduction of severe oral mucositis (SOM) in patients with head and neck cancer (HNC) and for the reduction of esophagitis in patients with lung cancer. The company has completed Phase III Reduction in Oral Mucositis with Avasopasem Manganese (ROMAN) trial of GC4419 for the reduction of radiotherapy-induced SOM in patients with locally advanced HNC. Its second dismutase mimetic product candidate, rucosopasem manganese (GC4711), is in clinical-stage development to augment the anti-cancer efficacy of stereotactic body radiation therapy (SBRT) in patients with non-small cell lung cancer (NSCLC) and locally advanced pancreatic cancer (LAPC).

Company Info

GALERA THERAPEUTICS INC

45 Liberty Blvd., Suite 230

Malvern PENNSYLVANIA 19355

P: 16107251500

CEO: J. Mel Sorensen

Employees: 31

Website: https://www.galeratx.com/

GRTX News

ChartMill News Image11 days ago - ChartmillLet's take a look at the stocks that are in motion in today's session.

Here are the top movers in Monday's session, showcasing the stocks with significant price changes.

ChartMill News Image12 days ago - ChartmillWhich stocks are experiencing notable movement on Monday?

Stay up-to-date with the latest market trends in the middle of the day on Monday. Explore the top gainers and losers during today's session in our detailed report.

ChartMill News Image12 days ago - ChartmillThere are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Monday.

The session on Monday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.

ChartMill News Image12 days ago - ChartmillTop movers in Monday's pre-market session

Let's have a look at what is happening on the US markets before the opening bell on Monday. Below you can find the top gainers and losers in today's pre-market session.

News Imagea month ago - InvestorPlaceGRTX Stock Earnings: Galera Therapeutics Reported Results for Q1 2024

Galera Therapeutics just reported results for the first quarter of 2024.

News Imagea month ago - Galera TherapeuticsGalera Reports First Quarter 2024 Financial Results and Recent Corporate Updates

Company’s evaluation of potential strategic alternatives progresses with goal to maximize stockholder value

GRTX Twits

Here you can normally see the latest stock twits on GRTX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example